Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD
- 20 April 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Clinical Oncology
- Vol. 17 (8), 475-492
- https://doi.org/10.1038/s41571-020-0356-4
Abstract
Allogeneic haematopoietic stem cell transplantation (allo-HSCT) was the first successful therapy for patients with haematological malignancies, predominantly owing to graft-versus-tumour (GvT) effects. Dramatic methodological changes, designed to expand eligibility for allo-HSCT to older patients and/or those with comorbidities, have led to the use of reduced-intensity conditioning regimens, in parallel with more aggressive immunosuppression to better control graft-versus-host disease (GvHD). Consequently, disease relapse has become the major cause of death following allo-HSCT. Hence, the prevention and treatment of relapse has come to the forefront and remains an unmet medical need. Despite >60 years of preclinical and clinical studies, the immunological requirements necessary to achieve GvT effects without promoting GvHD have not been fully established. Herein, we review learnings from preclinical modelling and clinical studies relating to the GvT effect, focusing on mechanisms of relapse and on immunomodulatory strategies that are being developed to overcome disease recurrence after both allo-HSCT and autologous HSCT. Emphasis is placed on discussing current knowledge and approaches predicated on the use of cell therapies, cytokines to augment immune responses and dual-purpose antibody therapies or other pharmacological agents that can control GvHD whilst simultaneously targeting cancer cells.Keywords
This publication has 194 references indexed in Scilit:
- Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA HypermethylationCancer Cell, 2012
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- Natural killer cells act as rheostats modulating antiviral T cellsNature, 2011
- Inducible Apoptosis as a Safety Switch for Adoptive Cell TherapyThe New England Journal of Medicine, 2011
- Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host DiseaseAmerican Journal of Transplantation, 2011
- Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs via Linked-Suppression in MiceTransplantation and Cellular Therapy, 2011
- Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemiaImmunology & Cell Biology, 2011
- Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivoNature Immunology, 2009
- All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulationThe Journal of Experimental Medicine, 2007
- A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanismThe Journal of Experimental Medicine, 2007